Is ServiceNow Stock a Buy After Its Brutal First Half?

ServiceNow shares are still ~50% below their 52-week high (~$211.48 vs ~$105), but the latest quarter shows the AI disruption thesis is easing: subscription revenue rose 22% YoY to $3.67B and cRPO increased 22.5% to $12.64B. Now Assist is tracking to ~$1.5B in annual contract value in 2026 (vs ~$1B target) with customers spending $1M+ on Now Assist up 130% YoY. Management guided full-year 2026 subscription revenue to ~$15.75B (+20%+) with 44% free-cash-flow margin in Q1, though the stock still trades at ~24x forward P/E and ~7x P/S, keeping valuation risk elevated.

Analysis

The market is still pricing NOW as if AI is a substitution shock to seat-based software, but the monetization mix is moving the other way. Workflow, connector, and usage-based pricing means more automation can lift consumption instead of shrinking it, so the key variable is not “AI helps or hurts” but whether attach rates can sustain growth once the current upsell cycle normalizes.

Near term, the stock can keep rerating if investors gain confidence that the AI contract value is real and durable rather than a one-quarter narrative boost. The bigger second-order beneficiary is NVDA: more automated workflows imply more inference demand, which is a volume lever even if software budgets flatten. By contrast, broad-suite vendors like CRM are more exposed to bundled-AI discounting because they have to defend share with pricing concessions, not just product claims.

The contrarian risk is that consensus is underweight a renewed bundle war. Microsoft, Salesforce, and Oracle can absorb AI costs inside larger contracts, which could slow net-new conversion over the next 1-3 quarters even if headline revenue stays healthy. Falsifier: if cRPO or large-deal growth meaningfully decelerates next quarter, the stock likely reverts toward the low-$100s because the current valuation still leaves little margin for error.

Key Decisions for Investors

• Initiate a small starter long in NOW over the next 2-4 weeks; preferred entry is on any 5-8% pullback or after a clean hold above the 20-day moving average. Risk/reward: acceptable for a modest 12-18 month holding period, but do not size it like a deep-value name.
• Pair trade: long NOW / short IGV for a 3-6 month window. Thesis is that NOW should outperform the software basket if the market rewards AI monetization instead of punishing software indiscriminately. Cover if relative strength breaks after the next earnings release.
• Use call spreads rather than outright calls if adding exposure into earnings. The stock is good, but not cheap; capped upside is preferable to paying full premium when multiple compression remains a live risk.
• Set a thesis stop: if next quarter cRPO growth slips below ~20% or large-deal growth loses momentum, reduce/exit the long. That would signal the AI tailwind is not strong enough to offset valuation risk.